Improved Pharmacokinetics with BAY 81-8973 Versus Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method: A Randomized Pharmacokinetic Study in Patients with Severe Hemophi...

por Shah, Anita, Solms, Alexander, Garmann, Dirk, Katterle, Yvonne, Avramova, Verzhiniya, Simeonov, Stanislav, Lissitchkov, Toshko
Publicado en Clin Pharmacokinet (2016)

octanate(®): over 20 years of clinical experience in overcoming challenges in haemophilia A treatment

por Klukowska, Anna, Komrska, Vladimír, Vdovin, Vladimír, Zozulya, Nadezhda, Lissitchkov, Toshko, Oldenburg, Johannes, Ettingshausen, Carmen Escuriola
Publicado en Ther Adv Hematol (2020)

Safety, Immunogenicity, and Hemostatic Efficacy of Nonacog Gamma in Patients With Severe or Moderately Severe Hemophilia B: A Continuation Study

por Windyga, Jerzy, Stasyshyn, Oleksandra, Lissitchkov, Toshko, Mamonov, Vasily, Serban, Margit, Rusen, Luminita, Ploder, Bettina, Tangada, Srilatha
Publicado en Clin Appl Thromb Hemost (2020)

An Open-Label Extension Study to Assess the Long-Term Efficacy and Safety of a Plasma-Derived von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Patients with von Wille...

por Lissitchkov, Toshko, Klukowska, Anna, Buevich, Evgeny, Maltceva, Irina, Auerswald, Guenter, Stasyshyn, Oleksandra, Seifert, Wilfried, Rogosch, Tobias
Publicado en J Blood Med (2020)

Pharmacokinetics, efficacy, and safety of a plasma-derived VWF/FVIII concentrate (VONCENTO) for on-demand and prophylactic treatment in patients with von Willebrand disease (SWIFT-...

por Lissitchkov, Toshko J., Buevich, Evgeny, Kuliczkowski, Kazimierz, Stasyshyn, Oleksandra, Cerqueira, Monica Hermida, Klukowska, Anna, Joch, Christine, Seifert, Wilfried
Publicado en Blood Coagul Fibrinolysis (2017)

Long‐term safety and efficacy of rIX‐FP prophylaxis with extended dosing intervals up to 21 days in adults/adolescents with hemophilia B

por Mancuso, Maria Elisa, Lubetsky, Aaron, Pan‐Petesch, Brigitte, Lissitchkov, Toshko, Nagao, Azusa, Seifert, Wilfried, Li, Yanyan, Santagostino, Elena
Publicado en J Thromb Haemost (2020)

Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A

por Shah, Anita, Solms, Alexander, Wiegmann, Sara, Ahsman, Maurice, Berntorp, Erik, Tiede, Andreas, Iorio, Alfonso, Mancuso, Maria Elisa, Zhivkov, Tihomir, Lissitchkov, Toshko
Publicado en Ann Hematol (2019)

Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A

por Solms, Alexander, Shah, Anita, Berntorp, Erik, Tiede, Andreas, Iorio, Alfonso, Linardi, Camila, Ahsman, Maurice, Mancuso, Maria Elisa, Zhivkov, Tihomir, Lissitchkov, Toshko
Publicado en Ann Hematol (2020)

Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia B

por Windyga, Jerzy, Timofeeva, Margarita, Stasyshyn, Oleksandra, Mamonov, Vasily, Lamas Castellanos, José Luis, Lissitchkov, Toshko, Chojnowski, Krzysztof, Chapman, Miranda, Pavlova, Borislava G., Tangada, Srilatha
Publicado en Clin Appl Thromb Hemost (2020)

Efficacy and safety of simoctocog alfa (Nuwiq®) in patients with severe hemophilia A: a review of clinical trial data from the GENA program

por Lissitchkov, Toshko, Klukowska, Anna, Pasi, John, Kessler, Craig M., Klamroth, Robert, Liesner, Raina J., Belyanskaya, Larisa, Walter, Olaf, Knaub, Sigurd, Bichler, Johann, Jansen, Martina, Oldenburg, Johannes
Publicado en Ther Adv Hematol (2019)

Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort

por Pasi, K. John, Lissitchkov, Toshko, Mamonov, Vasily, Mant, Tim, Timofeeva, Margarita, Bagot, Catherine, Chowdary, Pratima, Georgiev, Pencho, Gercheva‐Kyuchukova, Liana, Madigan, Kate, Van Nguyen, Huy, Yu, Qifeng, Mei, Baisong, Benson, Craig C., Ragni, Margaret V.
Publicado en J Thromb Haemost (2021)

Long-acting recombinant coagulation factor IX albumin fusion protein (rIX-FP) in hemophilia B: results of a phase 3 trial

por Santagostino, Elena, Martinowitz, Uri, Lissitchkov, Toshko, Pan-Petesch, Brigitte, Hanabusa, Hideji, Oldenburg, Johannes, Boggio, Lisa, Negrier, Claude, Pabinger, Ingrid, von Depka Prondzinski, Mario, Altisent, Carmen, Castaman, Giancarlo, Yamamoto, Koji, Álvarez-Roman, Maria-Teresa, Voigt, Christine, Blackman, Nicole, Jacobs, Iris
Publicado en Blood (2016)

Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients

por Lissitchkov, Toshko, Madan, Bella, Djambas Khayat, Claudia, Zozulya, Nadezhda, Ross, Cecil, Karimi, Mehran, Kavakli, Kaan, De Angulo, Guillermo R., Almomen, Abdulkareem, Subramanian, Kannan, D'Souza, Fulton, Viswabandya, Auro, Hoorfar, Hamid, Schwartz, Bruce A., Solomon, Cristina, Knaub, Sigurd, Peyvandi, Flora
Publicado en J Thromb Haemost (2020)